866-997-4948(US-Canada Toll Free)

Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation Devices, Interventional Neurology and Others

Published By :

GlobalData

Published Date : Sep 2010

Category :

Neurology Devices

No. of Pages : 119 Pages


GlobalDatas medical device report, Neurology Devices Market Outlook in Australia to 2016 Neurostimulation Devices, Interventional Neurology and Others provides key market data on the Australia Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Market size and company share data for Neurology Devices market categories CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology, and Radiosurgery
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Hydrocephalus Shunts, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Embolic Systems, Navigational Systems, CyberKnife Radiosurgery and Others.
  • 2009 company shares and distribution shares data for each of the five market categories.
  • Global corporate-level profiles of key companies operating within the Australia Neurology Devices market.
  • Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Cordis Corporation, Cyberonics, Inc. and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Explore investment opportunites in the market.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Content

1 Table of Contents
1.1 List of Tables 
1.2 List of Figures 

2 Introduction
2.1 What is This Report About? 

3 Neurology Devices In Australia
3.1 Neurology Devices, Market Segmentation 
3.2 Neurology Devices, Australia, Overall Revenue ($m), 2002-2016 
3.3 Neurology Devices Market, Australia, Revenue Mix ($m), 2009 
3.4 Neurology Devices Market, Australia, Category Contribution (%), 2009 
3.5 Neurology Devices, Australia, Category Volume (Units), 2002-2016 
3.6 Neurology Devices, Australia, Company Share (2008-2009) 

4 CSF Management In Australia
4.1 CSF Management, Market Segmentation 
4.2 CSF ManagementMarket, Australia, Revenue Mix ($m), 2009 
4.3 CSF Management Market, Australia, Segment Contribution (%), 2009 
4.4 CSF Management Overall Revenue (2002-2016) 
4.5 CSF Management Overall Volume (2002-2016) 
4.6 CSF Management Average Price (2002-2016) 
4.7 CSF Management Distribution Share (2008-2009) 
4.8 CSF Management, Australia, Company Share (2008-2009) 

5 Interventional Neurology In Australia
5.1 Interventional Neurology, Market Segmentation 
5.2 Interventional Neurology Market, Australia, Revenue Mix ($m), 2009 
5.3 Interventional Neurology Market, Australia, Segment Contribution (%), 2009 
5.4 Interventional Neurology Overall Revenue (2002-2016) 
5.4.1 Embolic Systems Revenue (2002-2016) 
5.4.2 Navigational Systems Revenue (2002-2016) 
5.5 Interventional Neurology Overall Volume (2002-2016)
5.5.1 Embolic Systems Volume (2002-2016) 
5.5.2 Navigational Systems Volume (2002-2016) 
5.6 Interventional Neurology Average Price (2002-2016)
5.7 Interventional Neurology Distribution Share (2008-2009) 
5.8 Interventional Neurology, Australia, Company Share (2008-2009) 

6 Neurostimulation Devices In Australia
6.1 Neurostimulation Devices, Market Segmentation 
6.2 Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2009 
6.3 Neurostimulation Devices Market, Australia, Segment Contribution (%), 2009 
6.4 Neurostimulation Devices Overall Revenue (2002-2016) 
6.5 Neurostimulation Devices Overall Volume (2002-2016) 
6.6 Neurostimulation Devices Average Price (2002-2016) 
6.7 Neurostimulation Devices Distribution Share (2008-2009) 
6.8 Neurostimulation Devices, Australia, Company Share (2008-2009) 

7 Neurosurgical Products In Australia
7.1 Neurosurgical Products Overall Revenue (2002-2016) 
7.2 Neurosurgical Products Overall Volume (2002-2016) 
7.3 Neurosurgical Products Average Price (2002-2016) 
7.4 Neurosurgical Products Distribution Share (2008-2009) 
7.5 Neurosurgical Products, Australia, Company Share (2008-2009) 

8 Overview of Key Companies in Australia Neurology Devices Market
8.1 Medtronic, Inc. 
8.1.1 Company Overview 
8.1.2 Share in the Australia Neurology Devices Market 
8.2 Boston Scientific Corporation
8.2.1 Company Overview 
8.2.2 Share in the Australia Neurology Devices Market 
8.3 Cordis Corporation
8.3.1 Company Overview 
8.3.2 Share in the Australia Neurology Devices Market 
8.4 Cyberonics, Inc.
8.4.1 Company Overview 
8.4.2 Share in the Australia Neurology Devices Market 
8.5 St. Jude Medical, Inc.
8.5.1 Company Overview 
8.5.2 Share in the Australia Neurology Devices Market 
8.6 ev3 Inc.
8.6.1 Company Overview 
8.6.2 Share in the Australia Neurology Devices Market 
8.7 B. Braun Melsungen AG
8.7.1 Company Overview 
8.8 Micrus Endovascular Corporation
8.8.1 Company Overview 
8.9 Integra LifeSciences Holdings Corporation
8.9.1 Company Overview 
8.10 KARL STORZ GmbH & Co. KG
8.10.1 Company Overview 
8.11 Terumo Corporation
8.11.1 Company Overview 
8.12 Codman & Shurtleff, Inc.
8.12.1 Company Overview 

9 Neurology Devices Market Pipeline Products

10. Recent Developments
10.1 Strategy And Business Planning 
10.1.1 Oct 10, 2009: Ambu Opens New Entity, Ambu Australia 
10.2 Government and Public Interest
10.2.1 Oct 15, 2009: 'ECG For The Mind' Could Diagnose Depression In An Hour 
10.3 Product News
10.3.1 Aug 19, 2010: MUH Performs Australia's First Gamma Knife surgery With Elekta’s Leksell Gamma Knife Perfexion System 

11 Appendix
11.1 Definitions of Markets Covered in the Report 
11.1.1 Neurology Devices 
11.2 Research Methodology
11.3 Secondary Research 
11.4 Primary Research 
11.5 Models 
11.6 Forecasts 
11.7 Expert Panels 
11.8 GlobalData Consulting 
11.9 Currency Conversion 
11.10 Contact Us 
11.11 Disclaimer 

List of Table


Table 1: Neurology Devices, Australia, Overall Revenue ($m), 2002-2016 13
Table 2: Neurology Devices Market, Australia, Category Contribution (%), 2009 15
Table 3: Neurology Devices, Australia, Cross-Category Analysis, 2002-2016 17
Table 4: Neurology Devices, Australia, Overall Revenue ($m), Historic, 2002-2009 19
Table 5: Neurology Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016 21
Table 6: Neurology Devices, Australia, Category Volume (Units), 2002-2016 22
Table 7: Neurology Devices, Australia, Category Volume (Units), Historic, 2002-2009 24
Table 8: Neurology Devices, Australia, Category Volume (Units), Forecast, 2009-2016 26
Table 9: Neurology Devices, Australia, Company Share by Revenue ($m), 2008-2009 28
Table 10: CSF Management Market, Australia, Segment Contribution (%), 2009 31
Table 11: CSF Management, Australia, Revenue ($m) by Segment, Historic, 2002-2009 33
Table 12: CSF Management, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 35
Table 13: CSF Management, Australia, Volume (Units) by Segment, Historic, 2002-2009 37
Table 14: CSF Management, Australia, Volume (Units) by Segment, Forecast, 2009-2016 39
Table 15: CSF Management, Australia, Average Price ($), Historic, 2002-2009 40
Table 16: CSF Management, Australia, Average Price ($), Forecast, 2009-2016 40
Table 17: CSF Management, Australia, Distribution Share by Revenue ($m), 2008-2009 41
Table 18: CSF Management, Australia, Company Share by Revenue ($m), 2008-2009 43
Table 19: Interventional Neurology Market, Australia, Segment Contribution (%), 2009 46
Table 20: Interventional Neurology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 48
Table 21: Interventional Neurology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 50
Table 22: Embolic Systems, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 52
Table 23: Embolic Systems, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 54
Table 24: Navigational Systems, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 56
Table 25: Navigational Systems, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 58
Table 26: Interventional Neurology, Australia, Volume (Units) by Segment, Historic, 2002-2009 60
Table 27: Interventional Neurology, Australia, Volume (Units) by Segment, Forecast, 2009-2016 62
Table 28: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 63
Table 29: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 64
Table 30: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 66
Table 31: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 67
Table 32: Interventional Neurology, Australia, Average Price ($), Historic, 2002-2009 68
Table 33: Interventional Neurology, Australia, Average Price ($), Forecast, 2009-2016 68
Table 34: Interventional Neurology, Australia, Distribution Share by Revenue ($m), 2008-2009 69
Table 35: Interventional Neurology, Australia, Company Share by Revenue ($m), 2008-2009 71
Table 36: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2009 74
Table 37: Neurostimulation Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 76
Table 38: Neurostimulation Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 78
Table 39: Neurostimulation Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 80
Table 40: Neurostimulation Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 82
Table 41: Neurostimulation Devices, Australia, Average Price ($), Historic, 2002-2009 83
Table 42: Neurostimulation Devices, Australia, Average Price ($), Forecast, 2009-2016 83
Table 43: Neurostimulation Devices, Australia, Distribution Share by Revenue ($m), 2008-2009 84
Table 44: Neurostimulation Devices, Australia, Company Share by Revenue ($m), 2008-2009 86
Table 45: Neurosurgical Products, Australia, Revenue ($m), Historic, 2002-2009 87
Table 46: Neurosurgical Products, Australia, Revenue ($m), Forecast, 2009-2016 88
Table 47: Neurosurgical Products, Australia, Volume (Units), Historic, 2002-2009 89
Table 48: Neurosurgical Products, Australia, Volume (Units), Forecast, 2009-2016 90
Table 49: Neurosurgical Products, Australia, Average Price ($), Historic, 2002-2009 91
Table 50: Neurosurgical Products, Australia, Average Price ($), Forecast, 2009-2016 91
Table 51: Neurosurgical Products, Australia, Distribution Share by Revenue ($m), 2008-2009 92
Table 52: Neurosurgical Products, Australia, Company Share by Revenue ($m), 2008-2009 93
Table 53: Neurology Devices Market Pipeline Products 105
Table 54: USD to Local Currency, Australia, Average Actual Rate 2002-2009 119

List of Chart


Figure 1: Neurology Devices, Market Segmentation 11
Figure 2: Neurology Devices, Australia, Overall Revenue ($m), 2002-2016 12
Figure 3: Neurology Devices Market, Australia, Revenue Mix ($m), 2009 14
Figure 4: Neurology Devices Market, Australia, Category Contribution (%), 2009 15
Figure 5: Neurology Devices, Australia, Cross-Category Analysis, 2002-2016 16
Figure 6: Neurology Devices, Australia, Overall Revenue ($m), Historic, 2002-2009 18
Figure 7: Neurology Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016 20
Figure 8: Neurology Devices, Australia, Category Volume (Units), 2002-2016 22
Figure 9: Neurology Devices, Australia, Category Volume (Units), Historic, 2002-2009 23
Figure 10: Neurology Devices, Australia, Category Volume (Units), Forecast, 2009-2016 25
Figure 11: Neurology Devices, Australia, Company Share (%), 2009 27
Figure 12: CSF Management, Market Segmentation 29
Figure 13: CSF Management Market, Australia, Revenue Mix ($m), 2009 30
Figure 14: CSF Management Market, Australia, Segment Contribution (%), 2009 31
Figure 15: CSF Management, Australia, Revenue ($m) by Segment, Historic, 2002-2009 32
Figure 16: CSF Management, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 34
Figure 17: CSF Management, Australia, Volume (Units) by Segment, Historic, 2002-2009 36
Figure 18: CSF Management, Australia, Volume (Units) by Segment, Forecast, 2009-2016 38
Figure 19: CSF Management, Australia, Company Share (%), 2009 42
Figure 20: Interventional Neurology, Market Segmentation 44
Figure 21: Interventional Neurology Market, Australia, Revenue Mix ($m), 2009 45
Figure 22: Interventional Neurology Market, Australia, Segment Contribution (%), 2009 46
Figure 23: Interventional Neurology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 47
Figure 24: Interventional Neurology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 49
Figure 25: Embolic Systems, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 51
Figure 26: Embolic Systems, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 53
Figure 27: Navigational Systems, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 55
Figure 28: Navigational Systems, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 57
Figure 29: Interventional Neurology, Australia, Volume (Units) by Segment, Historic, 2002-2009 59
Figure 30: Interventional Neurology, Australia, Volume (Units) by Segment, Forecast, 2009-2016 61
Figure 31: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 63
Figure 32: Embolic Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 64
Figure 33: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 65
Figure 34: Navigational Systems, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 67
Figure 35: Interventional Neurology, Australia, Company Share (%), 2009 70
Figure 36: Neurostimulation Devices, Market Segmentation 72
Figure 37: Neurostimulation Devices Market, Australia, Revenue Mix ($m), 2009 73
Figure 38: Neurostimulation Devices Market, Australia, Segment Contribution (%), 2009 74
Figure 39: Neurostimulation Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 75
Figure 40: Neurostimulation Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 77
Figure 41: Neurostimulation Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 79
Figure 42: Neurostimulation Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 81
Figure 43: Neurostimulation Devices, Australia, Company Share (%), 2009 85
Figure 44: Neurosurgical Products, Australia, Revenue ($m), Historic, 2002-2009 87
Figure 45: Neurosurgical Products, Australia, Revenue ($m), Forecast, 2009-2016 88
Figure 46: Neurosurgical Products, Australia, Volume (Units), Historic, 2002-2009 89
Figure 47: Neurosurgical Products, Australia, Volume (Units), Forecast, 2009-2016 90
Figure 48: Neurosurgical Products, Australia, Company Share (%), 2009 93
Figure 49: Medtronic, Inc., Company Share (%),Australia Neurology Devices Market, 2009 95
Figure 50: Boston Scientific Corporation, Company Share (%),Australia Neurology Devices Market, 2009 97
Figure 51: Cordis Corporation, Company Share (%),Australia Neurology Devices Market, 2009 98
Figure 52: Cyberonics, Inc., Company Share (%),Australia Neurology Devices Market, 2009 99
Figure 53: St. Jude Medical, Inc., Company Share (%),Australia Neurology Devices Market, 2009 101
Figure 54: ev3 Inc., Company Share (%),Australia Neurology Devices Market, 2009 102

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *